Work

Abstract 3816: Corilagin could help to overcome PARP inhibitor resistance by inhibiting ERK signaling pathways

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2019-3816

Authors: Baoxin Luan, Hongbo Zhao, Robert C. Bast, Zhen Lu, Yinhua Yu

Institutions: Fudan University, Obstetrics and Gynecology Hospital of Fudan University, The University of Texas MD Anderson Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4254881280

Cites:

Cited by:

Related to: 10